CID 130306983

Safusidenib

Structural Information

Molecular Formula
C25H18Cl3FN2O4
SMILES
CC1=CN(C2=CC=CC(=C12)/C=C/C(=O)O)C(=O)C3=C(ON=C3C4=C(C=C(C=C4Cl)Cl)Cl)C(C)(C)F
InChI
InChI=1S/C25H18Cl3FN2O4/c1-12-11-31(17-6-4-5-13(19(12)17)7-8-18(32)33)24(34)21-22(30-35-23(21)25(2,3)29)20-15(27)9-14(26)10-16(20)28/h4-11H,1-3H3,(H,32,33)/b8-7+
InChIKey
BOOMBLZEOHXPPX-BQYQJAHWSA-N
Compound name
(E)-3-[1-[5-(2-fluoropropan-2-yl)-3-(2,4,6-trichlorophenyl)-1,2-oxazole-4-carbonyl]-3-methylindol-4-yl]prop-2-enoic acid
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

2
References

45
Patents

534.0316 Da
Monoisotopic Mass

6.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 535.03888 223.4
[M+Na]+ 557.02082 235.6
[M-H]- 533.02432 230.1
[M+NH4]+ 552.06542 231.3
[M+K]+ 572.99476 228.5
[M+H-H2O]+ 517.02886 215.6
[M+HCOO]- 579.02980 224.4
[M+CH3COO]- 593.04545 240.9
[M+Na-2H]- 555.00627 217.2
[M]+ 534.03105 233.0
[M]- 534.03215 233.0
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe